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Prognosis in heart failure with preserved left ventricular
systolic function: prospective cohort study
Philip A MacCarthy, Mark T Kearney, James Nolan, Amanda J Lee, Robin J Prescott, Ajay M Shah,
W Paul Brooksby, Keith A A Fox
Chronic heart failure due to left ventricular systolic
impairment is characterised by a poor prognosis and
abnormalities of cardiac structure, autonomic and
neurohumoral function, and fluid and electrolyte
homoeostasis, all of which are thought to contribute to
the pathophysiology of this condition. However, some
studies have found that 30-50% of all patients with
chronic heart failure have preserved left ventricular
systolic function.1 Despite this, the natural course of the
condition in these patients is controversial, and their
pathophysiological characterisation poor. As a result,
optimum treatment strategies are unclear. We looked
at five year mortality in patients recruited to a large
cohort study of chronic heart failure, comparing those
having impairment of left ventricular function with
those having preserved function.
Participants, methods, and results
We have published details of the United Kingdom
heart failure evaluation and assessment of risk trial
(UK-HEART) previously.2 3 Five hundred and fifty
three unselected ambulant patients were prospectively
recruited from April 1993 to December 1995. Patients
were enrolled if they had had stable, symptomatic
chronic heart failure for at least three months (other
primary causes of symptoms were excluded). As well as
symptoms of chronic heart failure, all patients had evi-
dence of cardiac dysfunction documented at the index
assessment by one or more of the following: systolic left
ventricular dysfunction on echocardiography or radio-
nuclide ventriculography; cardiothoracic ratio > 0.55;
and pulmonary venous congestion and/or upper lobe
venous diversion on chest radiography. Left ventricular
hypertrophy was assessed from electrocardiography
(on the basis of Sokolow-Lyon criteria). All patients
had 24 hour ambulatory monitoring for arrhythmia
analysis and assessment of heart rate variability. A glo-
bal index of total heart rate variability—the standard
deviation of all normal R-R intervals (SDNN) (with a
low value indicating a disadvantageous neurohumoral
profile)—was derived from this recording. All patients
were logged on the NHS Central Register (part of the
Office of Population Censuses and Surveys), which
notified the investigators when patients died.
Most studies confirm that patients with an ejection
fraction ≥ 50% can be considered to have preserved left
ventricular systolic function. We therefore chose this
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Characteristics of 522 patients with chronic heart failure and preserved or impaired left ventricular systolic function. Values are means
(standard deviations) unless stated otherwise
Characteristic Preserved function (n=163) Impaired function (n=359) P value
Age 62.5 (10.7) 62.3 (9.10) 0.8*
No (%) of men 117 (72) 287 (80) 0.07†
NYHA class (No (%)):
I 3 (2) 7 (2) <0.001†
II 119 (73) 190 (53)
III 41 (25) 162 (45)
Hypertension (No (%)) 10 (6) 11 (3) 0.2†
Ischaemic heart disease (No (%)) 124 (76) 284 (79) 0.5†
Myocardial infarction (No (%)) 106 (65) 237 (66) 0.9†
Angiotensin converting enzyme inhibitor (No (%)) 127 (78) 294 (82) 0.4†
Median (interquartile range) frusemide dose (mg) 40 (40 to 80) 80 (40 to 80) <0.001[
 blocker (No (%)) 11 (7) 22 (6) 0.9[
Digoxin (No (%)) 23 (14) 75 (21) 0.09[
Creatinine (mol/l) 115 (39) 123 (42) <0.05*
Sodium (mmol/l) 139.9 (2.60) 139.6 (3.44) 0.3*
Potassium (mmol/l) 4.36 (0.43) 4.33 (0.51) 0.4*
Plasma glucose (mmol/l) 5.90 (2.82) 5.92 (2.31) 0.9*
Median (interquartile range) cardiothoracic ratio 0.50 (0.47 to 0.55) 0.53 (0.50 to 0.57) <0.001[
Left ventricular end systolic diameter (cm) 4.08 (0.96) 5.50 (0.98) <0.001*
Left ventricular end diastolic diameter (cm) 5.79 (1.01) 6.43 (0.95) <0.001*
Left ventricular hypertrophy (No (%)) 20 (12) 36 (10) 0.7†
Median (interquartile range) heart rate (beats/min) 69 (63 to 82) 76 (66 to 89) <0.001[
Non-sustained ventricular tachycardia (No (%)) 41 (25) 158 (44) <0.001†
Median (interquartile range) SDNN (ms) 115 (91 to 144) 110 (81 to 142) 0.1[
Total mortality at five years (No (%)) 41 (25) 151 (42) <0.001†
NYHA=New York Heart Association.
SDNN=standard deviation of all normal R-R intervals over 24 hours.
Left ventricular hypertrophy was determined on the basis of voltage criteria.
*Student’s t test (for normally distributed data).
†2 test (for categorical variables).
[Mann-Whitney U test (for non-normally distributed data).
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value to dichotomise patients into those with preserved
( ≥ 50%) and those with impaired ( < 50%) function.4
In all, 522 patients had adequate measurements of
ejection fraction, of whom 163 (31%) had values ≥ 50%
and 359 (69%) < 50%. Information on deaths was
recorded to April 2000, allowing five year survival status
to be determined for all patients. The table shows the
characteristics of the two groups and statistical methods.
Five year mortality was substantial in both groups
but significantly greater in patients with impaired left
ventricular systolic function (41.5% v 25.2%, P < 0.001).
Twenty five per cent of patients with preserved
function had non-sustained ventricular tachycardia.
Both groups had similar SDNN measurements, which
were lower than previously shown in age matched
healthy control subjects.5
Comment
Mortality is significantly greater in patients with
chronic heart failure and impaired left ventricular
systolic function than in those with preserved systolic
function. However, even the patients with preserved
systolic function have a 25% five year mortality. There-
fore, clinical heart failure itself has a poor long term
prognosis, irrespective of electrocardiographically
determined left ventricular systolic function. Auto-
nomic function was abnormal in both groups, and this,
allied to the presence of non-sustained ventricular
tachycardia and left ventricular hypertrophy, may con-
tribute to the high mortality found in the patients with
preserved systolic function.
Our findings add to those of a recent study by Kitz-
man et al, who found that patients with chronic heart
failure and preserved left ventricular systolic function
have similar, but not as severe, pathophysiological
derangements to those with impaired systolic func-
tion.4 These and our data suggest that established
treatments for systolic heart failure may also have a
role in patients with chronic heart failure and
preserved left ventricular systolic function.
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Should same anaesthetist do preoperative anaesthetic visit
and give subsequent anaesthetic? Questionnaire survey of
anaesthetists
Bruno Simini, Guido Bertolini for the GiViTI group (Gruppo italiano per la Valutazione degli
interventi in Terapia Intensiva)
The preoperative anaesthetic visit is done to assess the
patient’s fitness for surgery, to discuss the most appro-
priate anaesthetic technique, to reassure the patient, to
obtain informed consent, and to prescribe premedi-
cant drugs. Patients used to be visited by the doctor
who later anaesthetised them,1 but the preoperative
visit and the subsequent anaesthetic are now seldom
done by the same anaesthetist.2 Patients would rather
be anaesthetised by the doctor who saw them,3 but
anaesthetists’ opinions are unexplored.
Participants, methods, and results
In June 2002 we sent a questionnaire containing two
scenarios to anaesthetists belonging to the Gruppo
italiano per la Valutazione degli interventi in Terapia
Intensiva (GiViTI), a research network of Italian anaes-
thesia and intensive care units founded in 1991 to pro-
mote research and improve clinical practice. In
scenario A, “one patient, one anaesthetist,” patients are
anaesthetised by the anaesthetist who visited them. In
scenario B, “one patient, two anaesthetists,” one anaes-
thetist visits a patient and another physician adminis-
ters the anaesthetic. We asked anaesthetists which
scenario is used in their institution, which one they
preferred, and to pick from a list (drawn up by a panel
of senior anaesthetists, see box) at least one reason for
their choice. Assuming 50% preferences for both
choices (worst scenario for estimating sample size), we
needed 170 respondents to give a width of 15% for the
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